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Phosphorus in his phosphate PO4
3 conﬁguration is an essential
constituent of all life forms. Phosphate diesters are at the core of
nucleic acid structure, while phosphate monoester transmits
information under the control of protein kinases and phosphatases.
Due to these fundamental roles in biology it is not a surprise that
phosphate cellular homeostasis is under tight control. Inositol
pyrophosphates are organic molecules with the highest proportion
of phosphate groups, and they are capable of regulating many bio-
logical processes, possibly by controlling energetic metabolism and
adenosine triphosphate (ATP) production. Furthermore, inositol
pyrophosphates inﬂuence inorganic polyphosphates (polyP)
synthesis. The polymer polyP is solely constituted by phosphate
groups and beside other known functions, it also plays a role in
buffering cellular free phosphate [Pi] levels, an event that is ulti-
mately necessary to generate ATP and inositol pyrophosphate.
Although it is not yet clear how inositol pyrophosphates regulate
cellular metabolism, understanding how inositol pyrophosphates
inﬂuence phosphates homeostasis will help to clarify this important
link. In this review I will describe the recent literature on this topic,
with in the hope of inspiring further research in this fascinating area
of biology.
 2012 Elsevier Ltd.Open access under CC BY license. Introduction
Phosphate is one of the essential elements in life, representing about 1% of the human body weight
primarily in the form of hydroxyapatites, the major constituent of bone and teeth. Additionally,5.
 BY license. 
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the charged backbone of nucleic acids, such as RNA and DNA. Phosphate transfer reactions are also the
principal mean to transfer energy and information between organic molecules. In living organisms, the
macromolecule with the highest phosphate content is paradoxically referred to as inorganic poly-
phosphates (polyP). This polymer contains few to hundreds phosphate residues linked by phos-
phoanhydride, “high-energy” bonds, similar to the bond found in ATP. Because it does not possess
carbons is classiﬁed as ‘inorganic’, even if it is ubiquitous present in every living organism from bacteria
to human. Many speciﬁc biological functions have been attributed to polyP (Kornberg et al., 1999; Rao
et al., 2009) but due to its intrinsic chemical structure, this polymer mainly inﬂuences phosphate/
cations cellular viability. Between the organic (carbon containing) molecules, diphosphoinositol
pentakisphosphte (hereafter call IP7) has the peculiarity to possess seven phosphates groups, that is,
one in excess of the six carbon atoms of the inositol ring. IP7 belongs to a large family of molecules
commonly referred to as inositol pyrophosphates. Because several inositol pyrophosphates have the
unique property of possessing more phosphates than carbon atoms (Bennett et al., 2006), it is not
surprising that they have been linked to phosphate homeostasis. Unfortunately, the evidences sup-
porting this concept are quite scattered through time and have been obtained using a variety of
experimental models; in addition, they often address only single aspects of the complex cellular
phosphate homeostasis. Therefore, extensive investigation has not yet been performed to address the
connection between inositol pyrophosphates and phosphatemetabolism. This assay aims to review the
data present in literature with the objective of stimulating the interest in this fascinating area of
research.
Background
Before discussing the principal aim of this review it is necessary to introduce themain players of our
story, which are inositol pyrophosphate and polyP. I am only brieﬂy introduce inositol pyrophosphate
enzymology and functions as several other reviews on this topic have been published recently (Burton
et al., 2009; Saiardi, 2012; Shears, 2009).
Two distinct classes of proteins the inositol hexakisphosphates kinases (IP6Ks) and the diphos-
phoinositol pentakisphosphate kinases (PP-IP5Ks or IP7Ks) are capable of synthesizing inositol pyro-
phosphates. IP6Ks utilize ATP as a phosphate donor to phosphorylate IP6 to IP7, generation the isomer
5PP-IP5 (Fig. 1A), and inositol pentakisphosphate I(1,3,4,5,6)P5 to PP-IP4 (Saiardi et al., 1999, 2000;
Losito et al., 2009). Furthermore, at least in vitro, IP6Ks generate more complex molecules contain-
ing two or more pyrophosphate moieties, or even three-phosphate species (Draskovic et al., 2008;
Saiardi et al., 2001). Three IP6K isoforms referred to as IP6K1, 2, 3 exist in mammal; however, there
is a single IP6K in the yeast Saccharomyces cerevisiae called Kcs1.
The PP-IP5Ks enzymes, synthesize inositol pyrophosphate from IP6, but not from IP5, (Losito et al.,
2009) generating the isomer 1PP-IP5. Kinetic studies performed in vitro suggested that IP7, the 5PP-IP5
isomer generated by IP6Ks, is the primary substrate of this new enzyme, and this ﬁnding was
conﬁrmed in vivo by analysing PP-IP5K null yeast (vip1D) that accumulate the un-metabolized
substrate IP7 (Azevedo et al., 2009; Onnebo and Saiardi, 2009). Thus PP-IP5K is responsible for IP8,
isomer 1,5PP2-IP4 synthesis (Fig. 1A). Two PP-IP5K isoforms referred to as PP-IP5Ka and b exist in
mammal while a single PP-IP5K called Vip1 is present in S. cerevisiae.
Inositol pyrophosphates are hydrolysed by the diphosphoinositol-polyphosphate phosphohy-
drolases (DIPPs) (Safrany et al., 1998). Four mammalian enzymes DIPP1,2,3,4 have been identiﬁed,
while only one DIPP protein exists in S. cerevisiae called Ddp1. These phosphatases are promiscuous
enzymes able to hydrolyse inositol pyrophosphate as well as nucleotide analogues, such as diadenosine
hexaphosphate (Ap6A) (Caffrey et al., 2000; Fisher et al., 2002). More recently, it has been shown that
DIPPs also degrade polyP (Lonetti et al., 2011). Inositol pyrophosphates control the most disparate
biological processes, from telomere length to vesicular trafﬁcking. It is conceivable that all these
function can be focused on the fact that inositol pyrophosphates are controlling cellular energy
metabolism and consequently, ATP production. We have recently, demonstrated that inositol pyro-
phosphates control glycolysis and mitochondrial oxidative phosphorylation by both inhibiting the
glycolytic ﬂux and increasing mitochondrial activity (Szijgyarto et al., 2011).
Fig. 1. Inositol pyrophosphate and polyP chemical structures. A) The top molecule depicts the structure of the IP7 isomer 5PP-IP5
(5-diphosphoinositol pentakisphosphate) generated by the IP6K class of enzymes. On the bottom is depicted the structure of the IP8
isomer 1,5PP2-IP4 (1,5bis-diphosphoinositol tetrakisphosphate) generate by the sequential action of IP6K and PP-IP5K enzymes. B)
polyPmolecular structurewhere ‘n’ range from 1 to hundreds. Thus three-phosphate residues constituted the shorter polyPmolecule.
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encouraged to read the following comprehensive reviews (Kornberg et al., 1999; Rao et al., 2009). The
polyP polymer likely represents a phosphate buffer that is synthesized and degraded in function of
the phosphate needs of the cells. Furthermore, it also functions as a chelator of metal ions, thereby
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In bacteria for example, it inﬂuences pathogenicity (Brown and Kornberg, 2008) and in mammalian
cells it has been proposed to regulate ﬁbrinolysis and platelet aggregation (Caen and Wu, 2010). In
prokaryotes, polyP synthesis is carried out by a family of conserved polyP kinases (PPKs), whereas
degradation is mediated by several polyP phosphatases (Rao et al., 2009). In higher eukaryotes polyP
synthesis remains poorly characterized. A homologous of the bacterial PPK1 has been identiﬁed in the
amoeba Dictyostelium discoideum, although it may have been originated through bacterial gene
transfer. The same organism also shows an actin-like polyP kinase (DdPPK2) (Gomez-Garcia and
Kornberg, 2004). In yeast, Vtc4, a subunit of the vacuolar transporter chaperone complex, functions
as a polyP polymerase (Hothorn et al., 2009). Mammalian genomes do not contain genes homologous
to those encoding PPK1, or Vtc4. To the contrary, there are several mammalian proteins containing
actin-like domains that resemble DdPPK2. However, these peptides are poorly characterized, there-
fore, the mechanisms of polyP synthesis in higher eukaryotes are still largely unknown (Hooley et al.,
2008). PolyP catabolism in budding yeast is controlled at least by three polyP phosphatases: an
exo-polyphosphatase named Ppx1, which removes Pi from the end of polyP chains (Wurst et al., 1995),
and the endo-polyphosphatase Ppn1, which attacks internal phosphoanhydride bonds, hydrolysing
polyP molecules into oligophosphates of smaller size (Shi and Kornberg, 2005). A second endo-
polyphosphatase has recently been identiﬁed, as the yeast protein Ddp1. Thus the enzyme that
degrades inositol pyrophosphate is also capable of metabolising polyP. This metabolic feature is also
shared by the mammalian homologous proteins DIPPs (Lonetti et al., 2011). A gene homologous
to yeast Ppx1 protein was also identiﬁed in mammalian genome and called h-Prune (Tammenkoski
et al., 2008).
The facts
In humans alteration of phosphate metabolism is implicated in several pathological states. Higher
serum phosphate leads to vascular calciﬁcation and cardiovascular complications. Although only
very small amount of phosphate circulates in the serum, its concentration is tightly regulated and it
is independent from dietary phosphorus intake (de Boer et al., 2009). Therefore, it is not surprising
that intense research efforts are aimed to elucidate phosphate uptake and metabolism. IP6K2 was
initially cloned while searching for a novel mammalian intestinal phosphate transporter that the
group of Murer identiﬁed as PiUS (Phosphate inorganic Uptake Stimulator) (Norbis et al., 1997). Once
transfected into Xenopus oocytes, PiUS stimulated the cellular uptake of radioactive phosphate.
Subsequently, two groups discovered that PiUS was capable of converting IP6 to IP7 and rename it to
IP6K2 (Saiardi et al., 1999; Schell et al., 1999). The ability of inositol pyrophosphate to control the
uptake of phosphate is an evolutionary conserved feature; in fact, kcs1D yeast with undetectable
level of IP7 exhibits a reduced uptake of phosphate from the culture medium (Saiardi et al., 2004).
In mammals, regulation of phosphate homeostasis is not restricted to IP6K2, all three mammalian
IP6Ks are likely to play a role. A genome-wide study aimed at identifying genetic variations associated
with changes of serum phosphorus concentration identiﬁed IP6K3 (Kestenbaum et al., 2010). This
human genetic study identiﬁed two independent single nucleotide polymorphisms (SNP) at locus
6p21.31, which are localised within the ﬁrst intron of the IP6K3 gene. Interestingly, this study that
analysed more than 16,000 humans identiﬁed SNP variant in only seven genes. Three of which, the
sodium phosphate cotransporter type IIa, the calcium sensing receptor and the ﬁbroblast growth factor
23, are well known regulators of phosphate homeostasis. These evidences support a role for IP6K3 in
controlling serum phosphate levels in humans (Kestenbaum et al., 2010).
Work carried out in yeast substantiates this connection. In S. cerevisiae, phosphorus homeostasis is
under the control of the PHO pathway that in turn regulates the expression of a set of genes responsible
for phosphate metabolism. A classical model of the PHO pathway contemplates that the phosphory-
lation status of the transcription factor Pho4 regulates its nuclear-cytoplasmic shuttling. The cyclin–
cyclin-dependent kinase complex Pho80–Pho85 in association with the cyclin-dependent kinase
inhibitor Pho81, controls the phosphorylation status of Pho4. Under conditions of high phosphate
levels, Pho80–Pho85 phosphorylation of Pho4 determines its exit from the nucleus inhibiting tran-
scription of the PHO genes.
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encoded by Pho5, identiﬁed Plc1, Arg82 and Kcs1 (the metabolic pathway that leads to IP7 synthesis)
as responsible for the constitutive expression of Pho5 (Auesukaree et al., 2005). This report conﬁrms
previous arg82D and kcs1D yeast strains’ microarray analysis in which the de-repressed expression of
genes regulated by phosphate was identiﬁed (El Alami et al., 2003). Thus in the yeast mutants for
phospholipase C plc1D, inositol polyphosphates multi kinase arg82D, or inositol hexakisphosphate
kinase kcs1D, Pho5 is constitutively expressed while inwild type yeast Pho5 expression is repressed in
phosphate rich medium. Interestingly, this screen failed to identify Vip1 as regulator of Pho5
expression. Another systematic screens carried out in Schizosaccharomyces pombe failed to report any
link between the soluble inositol polyphosphate pathways and the expression of acid phosphatases, it
is unclear whether these mutants were tested (Henry et al., 2011). However, the S. pombe Vip1
homologous mutant (asp1D) was analysed; and showed to have a normal induction of the acidic
phosphatase in low phosphate condition (Henry et al., 2011). The fact that two genome-wide screens
failed to identify Vip1 as a regulator of the PHO pathways contrasts with the model proposed by the
Oshea’s group, suggesting a direct regulation by Vip1-generated IP7 of the Pho81–Pho80–Pho85
complex (Lee et al., 2007). According to this model, selective binding of the IP7 isoform 1PP-IP5
augmented the inhibitory activity of Pho81, thereby increasing Pho4 transcriptional efﬁcacy. This
group also demonstrates an increase of IP7 levels under low phosphate conditions (Lee et al., 2007).
This ﬁnding is in contrast with the observation that lowering phosphate medium concentration
dramatically reduces the levels of ATP required for IP7 synthesis (Boer et al., 2010). In fact, in a recent
report, exposure of WT yeast to phosphate-free medium for 20 min resulted in a decrease of intra-
cellular inositol pyrophosphate levels by 80%, without affecting IP6 levels (Lonetti et al., 2011).
Nevertheless, because homologous of Pho4 and Pho81 are absent in S. pombe and Pho80 and Pho85 in
this yeast are not involved in regulating the PHO pathway (Tanaka and Okayama, 2000), IP7-depen-
dent regulation of Pho81-Pho80–Pho85 cannot be considered a universal mechanism. Furthermore,
the PHO pathway seems to be absent in mammals where IP7 exerts a tight control on phosphorus
homeostasis (see above).
An additional genome-wide study implicated S. cerevisiae IP6K gene Kcs1, but not the PP-IP5K gene
Vip1 in controlling phosphate response (Nishizawa et al., 2008). The comprehensive mapping of Pho4
and RNA polymerase II subunit Rpo21 binding using a tiling array revealed that in low phosphate
conditions, Pho4 promotes transcription of antisense and intragenic RNAs in the Kcs1 locus without
affecting transcription of Vip1. The Pho4-regulated Kcs1 antisense transcript might be responsible for
the formation of the intragenic shorter Kcs1 mRNA (Nishizawa et al., 2008). The truncated Kcs1
enzyme generated under these conditions may possess different and yet unknown enzymatic
properties.
Taken together, these studies underline the fundamental role played by inositol pyrophosphates in
controlling yeast and mammalian phosphate homeostasis. It is therefore likely that an evolutionary
conserved mechanism exists that explains this connection. Thus, beside yeast-speciﬁc transcriptional
control, probably exist a metabolic link between inositol pyrophosphates and cellular phosphate
homeostasis. An important observation arose from two reports demonstrating that yeast not pos-
sessing inositol pyrophosphates, have low or undetectable levels of polyP polymer, which is the main
intracellular phosphate storage molecule. One study used 31P NMR to determine yeast polyP levels
(Auesukaree et al., 2005), while the second study biochemically extracted and resolved polyP by gel
electrophoresis (Lonetti et al., 2011). A similar analysis is reported in Fig. 2; yeast strains without
inositol pyrophosphates lack the metachromatic toluidine blue smear typical of polyP. Moreover, the
dynamic turnover of the high-energy inositol pyrophosphates is linked to polyP biosynthesis. The
decrease in levels and re-synthesis of both molecules occur in parallel during the phosphate overplus
assay, an assay where phosphates are initially withdrawn and then resupplied to the medium. The
same report also demonstrated that Ddp1, the enzyme that hydrolyses the pyrophosphate moiety of
inositol pyrophosphate, in yeast, as well as the human homologous DIPPs, are inorganic polyphosphate
endo-polyphosphatases (Lonetti et al., 2011). These data support a evolutionary conserved, metabolic
link between inositol pyrophosphate and the polyP polymer. Because polyP is buffering phosphates
and cations, understanding how inositol pyrophosphates regulate polyPmetabolismwill likely address
the question of how inositol pyrophosphates control cellular phosphate homeostasis.
Fig. 2. Absence of polyP in mutant yeast devoid of inositol pyrophosphates extracted polyP was resolved on polyacrylamide gel and
visualized with toluidine blue. This analysis revealed a striking correlation between the lack of inositol pyrophosphates and the
absence of the polyP polymer. While wild type (WT) yeast and ipk1D strain (IP5-2K null) possess inositol pyrophosphates the
following yeast do not, plc1D (phospholipase C null), arg82D (inositol polyphosphate multi kinase null), kcs1D (IP6K null), and
kcs1Dipk1D (double IP6K and IP5-2K null) (Azevedo et al., 2009; Onnebo & Saiardi, 2009).
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Although, inositol pyrophosphate may have acquired unique organism-speciﬁc functions, the
conserved ability of this class of molecules to regulate phosphate metabolism suggests an evolutionary
ancient role. In this last paragraph, I will formulate few hypotheses that I hope will stimulate further
research aimed at elucidating the biological link between phosphate, inositol pyrophosphates
and polyP.
Inositol pyrophosphates regulate the entry of phosphate into the cells (Norbis et al., 1997), sug-
gesting that they could affect phosphate uptake either directly (by stimulating a transporter, for
example) or a indirectly by helping ‘ﬁxing’ free phosphates in organic molecules. The cytosolic
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and its utilizationmaywell be coupled. For example, the synthesis of polyPmay be linked to phosphate
entry in the cell. Inositol pyrophosphate control of energy metabolism (Szijgyarto et al., 2011) affects
not only ATP levels but it can also alter the entire cellular balance of adenine nucleotides. Given that
phosphate transfer reactions mainly use ATP as a vehicle for the phosphate groups, inositol pyro-
phosphate could affect phosphate metabolism by regulating the adenylate cellular pool. Moreover, it is
tempting to speculate the existence of a feedback mechanism that coordinates the metabolic balance
between ATP, phosphate and inositol pyrophosphates.
Inositol pyrophosphates could either contribute to the regulation of polyP synthesis, play a role in
polyP degradation, or both. The yeast polyP polymerase has been identiﬁed with the subunit four
(Vtc4) of the vacuolar membrane transporter chaperone (VTC) complex (Hothorn et al., 2009). Inter-
estingly, pyrophosphates (Pi–Pi) dramatically accelerate the polyP polymerase reaction. It would
therefore be interesting to determine whether the pyrophosphate moiety of IP7 can stimulate polyP
vacuolar synthesis in a similar fashion. Similarly, it would be interesting to analyse the effect of inositol
pyrophosphates on controlling the activity of the actin-like DdIPK2 enzyme. It should be noted
however, that the existence even in yeast or Dictyostelium of other enzymes able to synthesize different
polyP pools cannot be excluded. Thus, wewill be able to validate and fully appreciate the role played by
inositol pyrophosphates on polyP synthesis only after the identiﬁcation of higher eukaryotes polyP-
synthesizing peptide/s.
An evolutionary conserved function for IP7 in regulating the synthesis of polyP would entail
a ‘primer’ role for the eukaryotic polyP kinases/synthetases. The pyrophosphate moiety of IP7 may
work as a docking and starting point for the enzyme synthesizing polyP. This event will trigger the
synthesis of polyP molecules with a fully phosphorylated inositol ring attached to one extremity. The
ubiquitous presence of very active exophosphatases requires that the polyP edges are protected.
Therefore, although IP7 may not be used as primer in the synthesis of polyP itself the attachment of IP7
to the polymer ends, it might still function as the “cap” structure, similarly to what is observed for
mRNA, thereby protecting it from degradation. The fact that yeast exophosphatase Ppx1 is unable to
degrade IP7 (Lonetti et al., 2011) suggests that IP6 at the edge of polyP can protect this polymer from the
action of exophosphatases.
Nudix hydrolyses, such as yeast DDP1 and mammalian DIPPs are remarkable enzymes that
metabolise three different substrate polyP, inositol pyrophosphates and adenine dimer. Controlling
both cellular levels of the two most phosphates rich molecules such as polyP and inositol pyro-
phosphates, and the levels of adenosine, these enzymes are ideal candidates to regulate energy
metabolism and ATP synthesis. Nudix hydrolases are considered cellular surveillance agents, that are
capable of regulating cellular homeostasis (McLennan, 2006). Although DDP1 are known to metab-
olise adenine dimers, IP7 and polyP, further research will be needed to fully appreciate the multi-
faceted activity of these hydrolyses. Little is known about the mechanisms by which these enzymes
are regulated and the speciﬁcity of the substrates. The yeast Ddp1 enzyme preferentially metabolises
polyP in vitro (Lonetti et al., 2011) and IP7 in vivo (Ingram et al., 2003), but to date, a comparative study
of the three substrates has not been performed in vivo. Further investigations are required to deﬁne
the role of DIPPs in controlling cellular energy production and phosphate homeostasis under phys-
iological conditions.
The most abundant form of organic phosphate on earth is IP6, or phytic acid, a molecule that is
highly abundant in plant seeds from which was originally characterised. In plant seeds, IP6
represents a phosphate storage molecule that it is hydrolysed during germination, releasing
phosphates and cations. It will be an astonishing twist of event if inositol pyrophosphates were
controlling the levels of their own precursor IP6 (Raboy, 2003), although due to the evolutionary
conserved ability of inositol pyrophosphate to control phosphate homeostasis we should not be
entirely surprised.
The analysis of yeast mutant that does not synthesize inositol pyrophosphates has revealed
a striking correlation between the lack of inositol pyrophosphates and the absence of polyP
(Auesukaree et al., 2005; Lonetti et al., 2011). In this regard, future investigation of the metabolic and
functional interconnection between these two classes of highly phosphorylated molecules will
certainly reward us with exciting discoveries.
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